RespireRx Pharmaceuticals Inc (fka RSPI)

[tregaron]

Let's say share price floats back to .10 by close today (and it's headed in that direction). That means Samyang can convert 15 million shares, assuming they can hold share price under .12 or so. Add 40 percent for the warrants and they control 21 million...plus any additional shares thay may already own or will buy between now and April.

In effect, Samyang has control of the company now in either scenario (conversion or default)...and it will have cost them a maximum of $2.3 million.

The only question in my mind is where does that leave current shareholders?